Dr. Andrew R. Martin is a Professor in Mechanical Engineering and the Director of the Aerosol Research Laboratory of Alberta (ARLA) at the University of Alberta in Edmonton, Alberta, Canada. He is licensed as a Professional Engineer by the Association of Professional Engineers and Geoscientists of Alberta (APEGA). He has worked previously in industrial R&D, based first in France and then in the United States, on projects related to medical device development, inhalation drug delivery, and clinical and preclinical programs investigating new applications of therapeutic gases in medicine.

In 2014, he joined the Faculty of Engineering at the University of Alberta. He has taught extensively within the undergraduate Mechanical Engineering program, and was the recipient of the 2017 Mechanical Engineering Club's Award for Excellence in Teaching and a 2019 Faculty of Engineering Undergraduate Teaching Award. He also teaches a specialized graduate course dedicated to the mechanics of respiratory drug delivery, and has regularly volunteered as a guest lecturer on inhalation drug delivery in the Pharmacy program. In 2019, he received a Great Supervisor award from the Faculty of Graduate Studies and Research, recognizing strong supervisory skills and mentorship of graduate students.

In industry and academia, Dr. Martin has been actively involved in the research community. He is a member of the Editorial Board of the Journal of Aerosol Medicine and Pulmonary Drug Delivery, and is an Associate Editor of Frontiers in Drug Delivery – Respiratory Drug Delivery. He currently serves as a member of the HQP Program Advisory Committee for the Canadian NanoMedicines Innovation Network, and previously served on the International Society for Aerosols in Medicine (ISAM) Executive Board from 2015-2021. He has published widely on diverse topics related to aerosols and gases in medicine, regularly presents at international conferences, and is lead or co-inventor on several granted and pending patents. He has received a number of prestigious international awards in recognition of his research contributions, including the Drug Delivery to the Lungs Emerging Scientist Award (2022), and the ISAM Young Investigator Award (2013).